Yi-Xin Su - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2016	1
2017	1
2021	2
2022	0

Page 1

Research progress on the treatment of advanced prostate cancer with Olaparib.

Su YX, Yu CF, Xue P, Li LL, Xiao KM, Chu XL, Zhu SJ. Su YX, et al. Neoplasma. 2021 Nov;68(6):1132-1138. doi: 10.4149/neo_2021_210627N856. Epub 2021 Nov 16. Neoplasma. 2021. PMID: 34779643 Review.

The Effectiveness and Safety of Cinobufotalin Injection as an Adjunctive Treatment for Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.

Li LL, Su YX, Mao Y, Jiang PY, Chu XL, Xue P, Jia BH, Zhu SJ. Li LL, et al. Among authors: su yx. Evid Based Complement Alternat Med. 2021 Feb 5;2021:8852261. doi: 10.1155/2021/8852261. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33628320 Free PMC article.

Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better?

Mi JL, Zhang B, Pan YF, Su YX, Fan JF, Liao SF, Qin XL, Yao DC, Tang HY, Jiang W. Mi JL, et al. Among authors: su yx. Oral Oncol. 2017 Nov;74:34-39. doi: 10.1016/j.oraloncology.2017.09.003. Oral Oncol. 2017. PMID: 29103749

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.

Dong YY, Xiang C, Lu JX, Su YX, Pan YF, Cai R, Zhang RJ, He ZK, Liu ML, Huang H, Bai X, Tang HY, Shi YH, Wang Y, Jiang W. Dong YY, et al. Among authors: su yx. Strahlenther Onkol. 2016 Jun;192(6):394-402. doi: 10.1007/s00066-016-0970-3. Epub 2016 May 23. Strahlenther Onkol. 2016. PMID: 27215563 English.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results